Rapid Nutrition Announces Capital Increase

February 3, 2020

Rapid Nutrition Announces Capital Increase

 

 

Switzerland – The Company announces that with reference to its media announcement of 9 January 2020, valid conversion notices from Investors and Management* have been received in respect of 4,474,867 New Shares. Following the conversion, the total number of shares in issue is 38'849'541.

 

The listing of 4,474,867 new ordinary shares  of Rapid Nutrition PLC will take place on Thursday, 6 February 2020.

 

 

About Rapid Nutrition

Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established based on its successful and proven weight loss supplement range which is exported worldwide and now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing number of wider services to the life sciences industry.

 

For more information, please visit http://rnplc.com

 

or contact Investor Relations: info@rnplc.com

 

*Disclosure: Director/PDMR Shareholding - Upon conversion Vesta Vanderbeken Non-Executive Director has purchased 100,000 Ordinary Shares at a price of €0.17 per Ordinary Share (the "Purchase"). Following the Conversion and total number of shares issued, Vesta Vanderbeken now holds a total of 100,0000 Ordinary Shares representing approximately less than 3% voting rights of the issued share capital of the Company.This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

 

Disclosure Requirement:

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).

 

Please reload